Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
NurExone Biologic: Technisches (täglich, wöchentlich, monatlich) & Analysten "Strong Buy"-Rating!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 939391 | ISIN: US1598641074 | Ticker-Symbol: RV6
Tradegate
28.03.24
19:13 Uhr
250,90 Euro
-0,20
-0,08 %
Branche
Pharma
Aktienmarkt
S&P 500
1-Jahres-Chart
CHARLES RIVER LABORATORIES INTERNATIONAL INC Chart 1 Jahr
5-Tage-Chart
CHARLES RIVER LABORATORIES INTERNATIONAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
249,20253,2028.03.
249,70252,4028.03.

Aktuelle News zur CHARLES RIVER LABORATORIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiCharles River (CRL) Extends Gene Therapy Deal With NUS Medicine2
21.03.Charles River Extends Gene Therapy Alliance with NUS Medicine2
18.03.Evaluating Charles River: Insights From 7 Financial Analysts2
18.03.Potential ban on Wuxi could benefit competitor Charles River, Evercore says3
15.03.Charles River (CRL) Extends Gene Therapy Offering With New Pact2
14.03.Charles River, Navega Therapeutics Enter Gene Therapy Mfg. Pact2
14.03.Charles River brokers gene therapy manufacturing pact with Navega Therapeutics2
14.03.Charles River inks viral vector production pact for Navega's chronic pain gene therapy2
14.03.Charles River, Navega Therapeutics Collaborates For Comprehensive Gene Therapy Manufacturing1
14.03.Here's Why You Should Retain Charles River (CRL) Stock Now2
12.03.American European seeks $100m Charles River Re cat bond to cover ShoreOne book2
04.03.DURECT and Charles River enter agreement for alzet in U.S., Canada5
04.03.DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line3
04.03.DURECT Corporation: DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET Product Line in U.S. and Canada90Partnership agreement will be the first-ever co-marketing and sales collaboration for the ALZET Osmotic Pumps Portfolio and Associated Product Line in the U.S. and Canada Both companies will jointly...
► Artikel lesen
01.03.Charles River Labs stock hits 52-week high3
26.02.Charles River Labs partners with Wheeler Bio to integrate CMC platform2
26.02.Charles River (CRL) Forges Collaboration With Wheeler Bio2
22.02.Charles River and Wheeler Bio partner on therapeutic discovery2
21.02.Charles River Labs posts gains for 2023 despite Q4 revenues falling nearly 8%4
21.02.Charles River, Wheeler Bio Partner to Accelerate Discovery to IND Submission2
Seite:  Weiter >>
82 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1